TIAA, FSB - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA, FSB ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$6,422
-45.4%
14,383
+0.2%
0.00%
Q1 2023$11,765
-47.4%
14,3480.0%0.00%
Q4 2022$22,383
-10.5%
14,3480.0%0.00%
Q3 2022$25,0000.0%14,3480.0%0.00%
Q2 2022$25,000
-90.2%
14,348
-58.2%
0.00%
-100.0%
Q1 2020$256,000
-38.2%
34,348
-72.6%
0.00%
-50.0%
Q4 2019$414,000
-5.0%
125,368
-41.1%
0.00%0.0%
Q3 2019$436,000
-30.4%
212,8090.0%0.00%
-33.3%
Q2 2019$626,000212,8090.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders